Vitamin D Status Is Associated With In-Hospital Mortality and Mechanical Ventilation: A Cohort of COVID-19 Hospitalized Patients.


Journal

Mayo Clinic proceedings
ISSN: 1942-5546
Titre abrégé: Mayo Clin Proc
Pays: England
ID NLM: 0405543

Informations de publication

Date de publication:
04 2021
Historique:
received: 10 09 2020
revised: 02 12 2020
accepted: 04 01 2021
pubmed: 15 3 2021
medline: 13 4 2021
entrez: 14 3 2021
Statut: ppublish

Résumé

To explore the possible associations of serum 25-hydroxyvitamin D [25(OH)D] concentration with coronavirus disease 2019 (COVID-19) in-hospital mortality and need for invasive mechanical ventilation. A retrospective, observational, cohort study was conducted at 2 tertiary academic medical centers in Boston and New York. Eligible participants were hospitalized adult patients with laboratory-confirmed COVID-19 between February 1, 2020, and May 15, 2020. Demographic and clinical characteristics, comorbidities, medications, and disease-related outcomes were extracted from electronic medical records. The final analysis included 144 patients with confirmed COVID-19 (median age, 66 years; 64 [44.4%] male). Overall mortality was 18%, whereas patients with 25(OH)D levels of 30 ng/mL (to convert to nmol/L, multiply by 2.496) and higher had lower rates of mortality compared with those with 25(OH)D levels below 30 ng/mL (9.2% vs 25.3%; P=.02). In the adjusted multivariable analyses, 25(OH)D as a continuous variable was independently significantly associated with lower in-hospital mortality (odds ratio, 0.94; 95% CI, 0.90 to 0.98; P=.007) and need for invasive mechanical ventilation (odds ratio, 0.96; 95% CI, 0.93 to 0.99; P=.01). Similar data were obtained when 25(OH)D was studied as a continuous variable after logarithm transformation and as a dichotomous (<30 ng/mL vs ≥30 ng/mL) or ordinal variable (quintiles) in the multivariable analyses. Among patients admitted with laboratory-confirmed COVID-19, 25(OH)D levels were inversely associated with in-hospital mortality and the need for invasive mechanical ventilation. Further observational studies are needed to confirm these findings, and randomized clinical trials must be conducted to assess the role of vitamin D administration in improving the morbidity and mortality of COVID-19.

Identifiants

pubmed: 33714594
pii: S0025-6196(21)00001-X
doi: 10.1016/j.mayocp.2021.01.001
pmc: PMC7834253
pii:
doi:

Substances chimiques

Vitamin D 1406-16-2
25-hydroxyvitamin D A288AR3C9H

Types de publication

Journal Article Observational Study

Langues

eng

Sous-ensembles de citation

IM

Pagination

875-886

Informations de copyright

Copyright © 2021 Mayo Foundation for Medical Education and Research. All rights reserved.

Auteurs

Angeliki M Angelidi (AM)

Department of Medicine, Beth Israel Deaconess Medical Center/Harvard Medical School, Boston, MA.

Matthew J Belanger (MJ)

Department of Medicine, Beth Israel Deaconess Medical Center/Harvard Medical School, Boston, MA.

Michael K Lorinsky (MK)

Department of Medicine, Beth Israel Deaconess Medical Center/Harvard Medical School, Boston, MA.

Dimitrios Karamanis (D)

Department of Economics, University of Piraeus, Greece.

Natalia Chamorro-Pareja (N)

Albert Einstein College of Medicine, Bronx, NY; Department of Medicine, Jacobi Medical Center, Albert Einstein College of Medicine, Bronx, NY.

Jennifer Ognibene (J)

Albert Einstein College of Medicine, Bronx, NY.

Leonidas Palaiodimos (L)

Albert Einstein College of Medicine, Bronx, NY; Department of Medicine, Jacobi Medical Center, Albert Einstein College of Medicine, Bronx, NY; Division of Hospital Medicine, Montefiore Medical Center, Albert Einstein College of Medicine, Bronx, NY.

Christos S Mantzoros (CS)

Department of Medicine, Beth Israel Deaconess Medical Center/Harvard Medical School, Boston, MA; Section of Endocrinology, VA Boston Healthcare System, Harvard Medical School, Boston, MA. Electronic address: mbelang1@bidmc.harvard.edu.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH